Literature DB >> 25935704

The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps.

Joep E G IJspeert1, Sascha C van Doorn1, Ymkje M van der Brug1, Barbara A J Bastiaansen2, Paul Fockens2, Evelien Dekker2.   

Abstract

BACKGROUND AND AIMS: The adenoma detection rate (ADR) is the most important surrogate quality parameter for colorectal cancer (CRC) prevention. However, serrated polyps also are precursors of CRC. Large, prospective studies comparing the detection rate of serrated polyps among endoscopists in an era of awareness about the malignant potential of serrated polyps have not yet been performed. We aimed to compare the proximal serrated polyp (PSP) detection rate and the clinically relevant serrated polyp (RSP) detection rate among endoscopists and to analyze the association between these parameters and the ADR.
METHODS: Colonoscopy data were retrieved in one expert center between January 2011 and July 2014 by using a structured reporting system, enabling prospective and automatic quality assessment. Endoscopists who performed at least 50 colonoscopies within the timeframe were included for analysis. Multivariate logistic regression was used to compare the ADR, PSP detection rate, and RSP detection rate among endoscopists. The association among these parameters was calculated by using the Pearson r correlation coefficient. All lesions were assessed by an expert pathologist.
RESULTS: In total, 16 endoscopists and 2088 colonoscopies were included for analysis. The PSP detection rate ranged from 2.9% to 18.6% (mean 10.4%) among endoscopists. Corrected for confounders, the odds ratio to detect ≥1 PSP, compared with endoscopists with the highest detection rate, ranged from 0.79 (95% confidence interval [CI], 0.41-1.52) to 0.12 (95% CI, 0.03-0.55). The PSP detection rate was highly correlated with the RSP detection rate (ρ 0.94; P < .001), ranging from 4.3% to 20.9% (mean 13.9%). The PSP detection rate moderately correlated with the ADR (0.55; P = .03), which ranged from 23.2% to 49.2% (mean 35.2%).
CONCLUSIONS: The PSP detection rate is widely variable among endoscopists, strongly correlated with the RSP detection rate, and moderately correlated with the ADR. These results suggest a high miss rate of RSPs among endoscopists with low rates of PSP detection. Future research should determine the association between endoscopists' PSP detection rates and the risk of interval cancer.
Copyright © 2015 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25935704     DOI: 10.1016/j.gie.2015.02.044

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  18 in total

1.  Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.

Authors:  Joseph C Anderson; Lynn F Butterly; Julia E Weiss; Christina M Robinson
Journal:  Gastrointest Endosc       Date:  2017-01-31       Impact factor: 9.427

2.  Impact of an Endoscopic Quality Improvement Program Focused on Adenoma Detection on Sessile Serrated Adenoma/Polyp Detection.

Authors:  Ronald G Racho; Murli Krishna; Susan G Coe; Colleen S Thomas; Julia E Crook; Nancy N Diehl; Michael B Wallace
Journal:  Dig Dis Sci       Date:  2017-04-25       Impact factor: 3.199

3.  The (ir)relevance of the abandoned criterion II for the diagnosis of serrated polyposis syndrome: a retrospective cohort study.

Authors:  Arne G C Bleijenberg; Joep E G IJspeert; Daniel Rodríguez-Alcalde; Sabela Carballal; Maurits R Visser; Maria Pellise; Jan Jacob Koornstra; Salman A Rana; Andrew Latchford; Francesc Balaguer; Evelien Dekker
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

Review 4.  Management of Serrated Polyps of the Colon.

Authors:  Claire Fan; Adam Younis; Christine E Bookhout; Seth D Crockett
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

5.  Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.

Authors:  Maryan Cavicchi; Gaëlle Tharsis; Pascal Burtin; Philippe Cattan; Franck Venezia; Gilles Tordjman; Agnès Gillet; Joëlle Samama; Karine Nahon-Uzan; David Karsenti
Journal:  Dig Dis Sci       Date:  2019-08-30       Impact factor: 3.199

6.  Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry.

Authors:  Joseph C Anderson; William Hisey; Todd A Mackenzie; Christina M Robinson; Amitabh Srivastava; Reinier G S Meester; Lynn F Butterly
Journal:  Gastrointest Endosc       Date:  2022-03-08       Impact factor: 10.396

7.  Interendoscopist variability in proximal colon polyp detection is twice higher for serrated polyps than adenomas.

Authors:  Jean-François Bretagne; Stéphanie Hamonic; Christine Piette; Jean-François Viel; Guillaume Bouguen
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

Review 8.  British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.

Authors:  James E East; Wendy S Atkin; Adrian C Bateman; Susan K Clark; Sunil Dolwani; Shara N Ket; Simon J Leedham; Perminder S Phull; Matt D Rutter; Neil A Shepherd; Ian Tomlinson; Colin J Rees
Journal:  Gut       Date:  2017-04-27       Impact factor: 23.059

9.  Linked color imaging enhances endoscopic detection of sessile serrated adenoma/polyps.

Authors:  Daisaku Fujimoto; Naoki Muguruma; Koichi Okamoto; Yasuteru Fujino; Kaizo Kagemoto; Yasuyuki Okada; Yoshifumi Takaoka; Yasuhiro Mitsui; Shinji Kitamura; Tetsuo Kimura; Hiroshi Miyamoto; Yoshimi Bando; Tomoko Sonoda; Tetsuji Takayama
Journal:  Endosc Int Open       Date:  2018-03-07

10.  Longer observation time increases adenoma detection in the proximal colon - a prospective study.

Authors:  Peter Klare; Henrik Phlipsen; Bernhard Haller; Henrik Einwächter; Andreas Weber; Mohamed Abdelhafez; Monther Bajbouj; Hayley Brown; Roland M Schmid; Stefan von Delius
Journal:  Endosc Int Open       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.